Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
UK patients seeking weight management treatment should speak to their GP about currently licensed options, including semaglutide (Wegovy) and tirzepatide (Mounjaro), in line with NICE guidance
Ispaghula is contraindicated in individuals with bowel obstruction, faecal impaction, undiagnosed abdominal pain, or known hypersensitivity to ispaghula
Cymbal, Michael et al
Some prescribing professionals have noted that when prescribing GLP1-RA for individuals with diabetes and MCAS, that the individuals also experienced improvements in inflammatory symptoms connected to MCAS
US$ 25.55
US$ 29.24
US$ 20.72
US$ 24.01
US$ 28.08
US$ 28.32
